Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NK1 receptor antagonist synthesized by RPR

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

Innapharma reports novel antidepressant

Dec. 19, 1996

Bayer describes new ASA derivatives

Dec. 19, 1996

Sandoz reports on tetraline derivatives for neurological disorders

Dec. 18, 1996

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Dec. 18, 1996

Novel GABA uptake inhibitors from Novo Nordisk

Dec. 18, 1996

Glycine therapy as a potential new approach to schizophrenia Rx

Dec. 17, 1996

Rizatriptan goes head-to-head with sumatriptan in migraine patients

Dec. 17, 1996

Cortex notified of broad patent covering calpain inhibitors

Dec. 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.